INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 3.680
0.00 (0.00%)
At close: Dec 5, 2025
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 290.36 million as of December 5, 2025. Its market cap has increased by 36.57% in one year.
Market Cap
290.36M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.68
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has decreased from 452.37M to 290.36M, a decrease of -35.81%. That is a compound annual growth rate of -12.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 290.36M | -23.02% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.53B |
| Nordhealth AS | 2.91B |
| Photocure ASA | 1.76B |
| Thor Medical ASA | 1.49B |
| ArcticZymes Technologies ASA | 1.02B |
| Omda AS | 955.66M |
| Vistin Pharma ASA | 917.93M |
| Gentian Diagnostics ASA | 845.14M |